// App-Quantinova.ai

2644 : Outcomes Of Tyrosine Kinase Inhibitors In Combination With Various Treatments Regimens In Adult Patients With Philadelphia Chromosome Positive Acute Lymphocytic Leukemia

Researchers

Presenter

  • Andrew Lin

Principal Investigators

  • Qin Zhou

  • Sean Devlin

  • Nelly G. Adel

  • Dan Douer

Medical Centers

  • Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY

  • Department of Surgery, Gynecologic Service, Memorial Sloan-Kettering Cancer Center, New York, NY

  • Lymphoma Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Ph chromosome

  • Tumor protein p63

Drug/Treatment

  • Vincristine

  • dasatinib

  • Imatinib

  • IkT001

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved